Nalaganje...

Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model

Antiviral drug resistance is the most important factor contributing to treatment failure using nucleos(t)ide analogs such as lamivudine for chronic infection with hepatitis B virus (HBV). Development of a system supporting efficient replication of clinically resistant HBV strains is imperative, and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Jingmin Zhang, Yafeng Wang, Youmei Peng, Chongzhen Qin, Yixian Liu, Jingjing Li, Jinhua Jiang, Yubing Zhou, Junbiao Chang, Qingduan Wang
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2018-11-01
Serija:Brazilian Journal of Infectious Diseases
Online dostop:http://www.sciencedirect.com/science/article/pii/S1413867018304975
Oznake: Označite
Brez oznak, prvi označite!